Relationship between the ABO blood group and Rhesus factors with COVID-19 susceptibility. 2023

Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
The Combined Military Hospital Lahore, Pakistan.

The molecular research has raised copious hypotheses about different molecular effects on the variable expression of the current virus on the human body. The present prospective study aims to determine clinically as well as statistically, the relation between ABO blood groups and Rhesus (Rh) factor and the severity of the Covid-19 virus. We conducted a prospective, single-centered study at The Combined Military Hospital Lahore, Pakistan. Details of only those patients who exhibit COVID-19 symptoms were included. The odds ratios with a 95% confidence interval and the chi-square test of blood groups and Rhesus factor was also conducted individually with the severity of disease, outcomes, and respiratory symptoms. P-values less than 0.05 was considered significant. The chi-square test and odd ratio yielded no significant results when the covid-19 status was compared with the Rhesus factor (p-value > 0.05). However, the results were found to be significant when associations were run between Covid-19 status and all the blood groups (p-value < 0.05). According to the analytical results of the present study, protective nature of all the blood antigens (A, B, AB, none) was observed in patients presenting with Covid-19 symptoms of varying severity.

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D012204 Rh-Hr Blood-Group System Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. Rh Factors,Rhesus Blood-Group System,Antigen D, Rh Blood Group,Blood-Group System, Rh-Hr,Blood-Group System, Rhesus,Blood-Group Systems, Rh-Hr,Blood-Group Systems, Rhesus,Factor, Rh,Factors, Rh,Rh Factor,Rh Hr Blood Group System,Rh-Hr Blood-Group Systems,Rhesus Blood Group System,Rhesus Blood-Group Systems,System, Rh-Hr Blood-Group,System, Rhesus Blood-Group,Systems, Rh-Hr Blood-Group,Systems, Rhesus Blood-Group

Related Publications

Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
July 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
January 2021, Blood transfusion = Trasfusione del sangue,
Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
January 2020, Frontiers in cellular and infection microbiology,
Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
January 2023, Cambridge prisms. Precision medicine,
Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
January 2021, Blood transfusion = Trasfusione del sangue,
Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
October 2020, Clinica chimica acta; international journal of clinical chemistry,
Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
January 2022, Hematology, transfusion and cell therapy,
Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
November 2021, New microbes and new infections,
Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
January 2024, PloS one,
Sameer Ijaz, and Ali Hamza Cheema, and Anum Rafiq, and Asma Asghar, and Abdul Rehman Shah Syed, and Abdul Ahad Syed, and Farea Eqbal, and Hassan Mumtaz
May 2009, Digestive diseases and sciences,
Copied contents to your clipboard!